Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

NCT02492750 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Indolent Plasma Cell Myeloma
Plasma Cell Myeloma
Smoldering Plasma Cell Myeloma

Interventions

BIOLOGICAL: Anakinra
DRUG: Dexamethasone
OTHER: Laboratory Biomarker Analysis
DRUG: Lenalidomide
OTHER: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]